John Wiley & Sons

SHERPA: Green

People

  1. Abou-Alfa
    Abou-Alfa
  2. Kelsen
    Kelsen
  3. O'Reilly
    O'Reilly
  4. Bains
    Bains
  5. Epstein
    Epstein
  6. Gonen
    Gonen
  7. Jarnagin
    Jarnagin
  8. Kemeny
    Kemeny
  9. Saltz
    Saltz
  10. Breitbart
    Breitbart

Groups

  1. Department of Medicine (37)
  2. Gastrointestinal Oncology Service (37)
  3. Solid Tumor Oncology Division (37)
  4. Center for Pancreatic Cancer Research (15)
  5. Surgery (8)
  6. Survivorship Research (7)
  7. Biostatistics Service (4)
  8. Epidemiology and Biostatistics (4)
  9. GSK Faculty (3)
  10. Hematologic Malignancies, Division of (3)
Search Within
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (13)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (37)
  2. Gastrointestinal Oncology Service (37)
  3. Solid Tumor Oncology Division (37)
  4. Center for Pancreatic Cancer Research (15)
  5. Surgery (8)
  6. Survivorship Research (7)

More Groups

People
  1. Ghassan Abou-Alfa (14)
  2. David Kelsen (6)
  3. Eileen O'Reilly (5)
  4. Nancy Kemeny (5)
  5. Andrew Epstein (3)
  6. James Harding (3)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Hepatology (13)
  2. Seminars in Surgical Oncology (6)
  3. International Journal of Cancer (5)
  4. Psycho-Oncology (3)
  5. Annals of the New York Academy of Sciences (2)
  6. Pharmacoepidemiology and Drug Safety (2)

More Publications

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
    Meeting Abstract

    O'Reilly, E.; Li, J.; DerSarkissian, M.; Chang, R.; Cheng, M.; Yu, L.; Rane, D.; Zhang, L.; Xiao, Z.; Benzaghou, F.; more...
    Pharmacoepidemiology and Drug Safety (2024)

    Fulltext@MSK | Save
  • Outcomes by comorbidities with tremelimumab and durvalumab in the phase 3 Himalaya study in unresectable hepatocellular carcinoma
    Meeting Abstract

    Rimassa, L.; Dayyani, F.; Kelley, R. K.; Sangro, B.; Chan, S. L.; McCoy, C. L.; Paskow, M. J.; Makowsky, M.; Gupta, C.; Ran, D.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Five-year overall survival and overall survival by tumor response measures from the phase 3 Himalaya study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Rimassa, L.; Chan, S.; Sangro, B.; Lau, G.; Kudo, M.; Breder, V.; Varela, M.; Crysler, O.; Bouattour, M.; Dao, T. V.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Non-viral etiology subgroup of the phase 3 Himalaya study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Reig, M.; Tam, V.; Sangro, B.; Archambeaud, I.; Kelley, R. K.; Chan, S.; Kudo, M.; Masi, G.; Paskow, M.; Makowsky, M.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients
    Journal Article

    Lee, V.; Parkinson, R.; Zahurak, M.; Cope, L.; Cercek, A.; Verheul, H.; Gootjes, E.; Lenz, H. J.; Iqbal, S.; Jones, P.; more...
    International Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Chan, S. L.; Kelley, K.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; De Toni, E. N.; Furuse, J.; Kang, Y. K.; Galle, P. R.; more...
    Hepatology (2023)

    Fulltext@MSK | Save
  • Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy
    Journal Article

    Boerner, T.; Carr, R. A.; Hsu, M.; Michel, A.; Tan, K. S.; Vos, E.; Sihag, S.; Bains, M. S.; Ku, G. Y.; Wu, A. J.; more...
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405
    Journal Article

    Van Blarigan, E. L.; Ma, C.; Ou, F. S.; Bainter, T. M.; Venook, A. P.; Ng, K.; Niedzwiecki, D.; Giovannucci, E.; Lenz, H. J.; Polite, B. N.; more...
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study
    Meeting Abstract

    Vogel, A.; Chan, S. L.; Furuse, J.; Tak, W. Y.; Masi, G.; Varela, M.; Kim, J. H.; Tanasanvimon, S.; Reig, M.; Dayyani, F.; more...
    Hepatology (2022)

    Fulltext@MSK | Save
  • Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
    Journal Article

    Ahn, J. C.; Lauzon, M.; Luu, M.; Noureddin, M.; Ayoub, W.; Kuo, A.; Sundaram, V.; Kosari, K.; Nissen, N.; Gong, J.; more...
    Hepatology (2022)

    Fulltext@MSK | Save